We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Slowing ribosome velocity restores folding and function of mutant CFTR.
- Authors
Oliver, Kathryn E.; Rauscher, Robert; Mijnders, Marjolein; Wei Wang; Wolpert, Matthew J.; Maya, Jessica; Sabusap, Carleen M.; Kesterson, Robert A.; Kirk, Kevin L.; Rab, Andras; Braakman, Ineke; Jeong S. Hong; Hartman IV, John L.; Ignatova, Zoya; Sorscher, Eric J.; Wang, Wei; Hong, Jeong S; Hartman, John L 4th
- Abstract
Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR), with approximately 90% of patients harboring at least one copy of the disease-associated variant F508del. We utilized a yeast phenomic system to identify genetic modifiers of F508del-CFTR biogenesis, from which ribosomal protein L12 (RPL12/uL11) emerged as a molecular target. In the present study, we investigated mechanism(s) by which suppression of RPL12 rescues F508del protein synthesis and activity. Using ribosome profiling, we found that rates of translation initiation and elongation were markedly slowed by RPL12 silencing. However, proteolytic stability and patch-clamp assays revealed RPL12 depletion significantly increased F508del-CFTR steady-state expression, interdomain assembly, and baseline open-channel probability. We next evaluated whether Rpl12-corrected F508del-CFTR could be further enhanced with concomitant pharmacologic repair (e.g., using clinically approved modulators lumacaftor and tezacaftor) and demonstrated additivity of these treatments. Rpl12 knockdown also partially restored maturation of specific CFTR variants in addition to F508del, and WT Cftr biogenesis was enhanced in the pancreas, colon, and ileum of Rpl12 haplosufficient mice. Modulation of ribosome velocity therefore represents a robust method for understanding both CF pathogenesis and therapeutic response.
- Subjects
VELOCITY; RIBOSOMAL proteins; PROTEIN synthesis; CYSTIC fibrosis; COLON (Anatomy); PROTEIN metabolism; AMINOPYRIDINES; ANIMAL experimentation; BIOCHEMISTRY; BRONCHI; COMPARATIVE studies; CYTOLOGY; CYTOPLASM; EPITHELIAL cells; EPITHELIUM; GENES; HETEROCYCLIC compounds; ILEUM; PHENOMENOLOGY; RESEARCH methodology; MEDICAL cooperation; MEMBRANE proteins; MICE; MOLECULAR structure; GENETIC mutation; PANCREAS; PROTEINS; RATS; RESEARCH; EVALUATION research; INDOLE compounds
- Publication
Journal of Clinical Investigation, 2019, Vol 129, Issue 12, p5236
- ISSN
0021-9738
- Publication type
journal article
- DOI
10.1172/JCI124282